BIKTARVY and Doxycycline Co-administration Safety

Mechanism and Interaction Profile

BIKTARVY contains bictegravir, which is an integrase strand transfer inhibitor (InSTI) with minimal drug-drug interactions with medications metabolized through the CYP450 pathway 1
Doxycycline is not known to have significant interactions with InSTI-based regimens like BIKTARVY 2
Unboosted InSTI-based regimens like BIKTARVY are recommended specifically because they have fewer drug-drug interactions compared to other antiretroviral classes 3
Bictegravir does not significantly induce or inhibit CYP450 enzymes, making it compatible with many medications including antibiotics like doxycycline 1

InSTI-based regimens such as BIKTARVY are preferred when co-administered with other medications due to their favorable drug interaction profiles 2
No dose adjustments are required for either BIKTARVY or doxycycline when used together 1
For patients requiring both HIV treatment and antibiotics for conditions such as infections, BIKTARVY maintains its efficacy without compromising the effectiveness of doxycycline 4

While BIKTARVY has minimal interactions with doxycycline, be aware that certain other medications may interact with either drug independently 1
Unlike some antiretrovirals, BIKTARVY and doxycycline can be taken without specific timing requirements related to antacids 5

Regular monitoring of HIV viral load is recommended to ensure continued virological suppression when BIKTARVY is co-administered with any medication, including doxycycline 6

In patients with renal impairment, BIKTARVY can be used if creatinine clearance is above 30 mL/min/1.73 m², while doxycycline does not require dose adjustment in renal impairment 7